LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/Denying Obese Patients Joint Surgery Is a Dead End
Large Joints and Extremities

Denying Obese Patients Joint Surgery Is a Dead End

July 5, 2019 2 min read Premium comments

Advertisement

Denying Obese Patients Joint Surgery Is a Dead End
Source: Wikimedia Commons and TDorante10 and RRY Publications
#totaljointarthroplastySecondary#morbidlyobese

One might think that simply putting restrictions on elective total joint surgery for those who are severely overweight might encourage weight loss.

Not necessarily so, says new work from OrthoCarolina and Novant Health Bariatric Solutions. Such an endeavor requires a different, more problem solving and supportive approach, says new research.

The study, “What are the implications of withholding total joint arthroplasty in the morbidly obese? a prospective, observational study,” appears in the June 30, 2019 edition of The Bone and Joint Journal.

Bryan Springer, M.D., associate professor in the Department of Orthopedic Surgery at OrthoCarolina and co-author explained both the problem and the, perhaps, counterintuitive outcome to OTW, “We know that total joint arthroplasty in the morbidly obese (Body Mass Index (BMI) > 40) carries with it a higher risk of complications, including infection.”

“It has been our policy in our practice to restrict the morbidly obese from having elective total joint arthroplasty until they could optimize their weight. We were curious however how often these patients were actually able to lose weight by simply saying they could not have surgery. The concern was that we were not offering them resources to assist in weight loss prior to surgery.”

“We looked at nearly 300 patients that were morbidly obese and otherwise would have qualified for total joint replacement (end stage OA [osteoarthritis] and failure of conservative management). We followed them for 2 years. What we found was that very few (only 19%) went on to have total joint replacement and of those very few actually had their BMI < 40. For those patients that did not have surgery, they were unable to lose weight and in fact their weight increased. Over 1/3 of the patients never came back to our office.”

“One thing people might interpret from this study is that patients can’t lose weight so you might as well go ahead and do their surgery anyway. That is not the message. As stated previously we know these patients are at higher risk. The message from this study is that patients need help and they need resources to help them lose weight. Just like we would provide them with resources to optimize their cardiac condition, their diabetes etc., we need to do the same to manage obesity.”

“If we are going to put barriers in place (restrictions) then we must provide resources and solutions. From this work, our group has established a patient optimization program that partners with bariatric and weight loss center at our institution to ensure patients have resources and help to become as optimized as possible prior to surgery.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy